On September 7, 2022 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will present at the following healthcare conferences in September (Press release, UroGen Pharma, SEP 7, 2022, View Source [SID1234619148]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright & Co. Annual Global Investment Conference

Tuesday, September 13 at 10:30 a.m. ET
Ladenburg Thalmann Healthcare Conference

Analyst Discussion on Thursday, September 29 at 8:30 a.m. ET
Webcasts of both the H.C. Wainwright & Co. and Ladenburg Thalmann presentations will be available via the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the Company’s website for approximately 30 days.